Cogent Biosciences Stock Analysis

Cogent Stock Analysis Notes

About 100.0% of the company shares are held by institutions such as insurance companies. The book value of Cogent Biosciences was currently reported as 2.09. The company recorded a loss per share of 2.49. Cogent Biosciences last dividend was issued on the 9th of November 2020. The entity had 1:4 split on the 9th of November 2020. Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. Cogent Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 77 people. For more info on Cogent Biosciences please contact Andrew MBA at 617 945 5576 or go to https://www.cogentbio.com.

Cogent Biosciences Investment Alerts

Cogent Biosciences Upcoming and Recent Events

Cogent Largest EPS Surprises

View All Earnings Estimates

Cogent Biosciences Environmental, Social, and Governance (ESG) Scores

Cogent Stock Institutional Investors

Note, although Cogent Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Cogent Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 765.86 M.

Cogent Profitablity

Management Efficiency

Cogent Biosciences has return on total asset (ROA) of (0.3843) % which means that it has lost $0.3843 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.657) %, meaning that it created substantial loss on money invested by shareholders. Cogent Biosciences' management efficiency ratios could be used to measure how well Cogent Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.64 in 2024. Return On Capital Employed is likely to drop to -0.79 in 2024. At this time, Cogent Biosciences' Non Current Liabilities Other is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 14.4 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 21.1 M in 2024.

Technical Drivers

As of the 4th of June, Cogent Biosciences shows the Risk Adjusted Performance of 0.0407, mean deviation of 3.5, and Downside Deviation of 4.02. Cogent Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Cogent Biosciences, which can be compared to its peers. Please confirm Cogent Biosciences variance, as well as the relationship between the value at risk and skewness to decide if Cogent Biosciences is priced correctly, providing market reflects its regular price of 8.38 per share. Given that Cogent Biosciences has jensen alpha of 0.2619, we suggest you to validate Cogent Biosciences's prevailing market performance to make sure the company can sustain itself at a future point.

Cogent Biosciences Price Movement Analysis

Cogent Biosciences Insider Trading Activities

Cogent Biosciences Predictive Daily Indicators

Cogent Biosciences Corporate Filings

Cogent Biosciences Forecast Models

Cogent Biosciences' time-series forecasting models are one of many Cogent Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cogent Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cogent Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cogent shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cogent Biosciences. By using and applying Cogent Stock analysis, traders can create a robust methodology for identifying Cogent entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cogent analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cogent analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Cogent Biosciences stock analysis indicators help investors evaluate how Cogent Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Cogent Biosciences shares will generate the highest return on investment. By understating and applying Cogent Biosciences stock analysis, traders can identify Cogent Biosciences position entry and exit signals to maximize returns.

When running Cogent Biosciences' price analysis, check to measure Cogent Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cogent Biosciences is operating at the current time. Most of Cogent Biosciences' value examination focuses on studying past and present price action to predict the probability of Cogent Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cogent Biosciences' price. Additionally, you may evaluate how the addition of Cogent Biosciences to your portfolios can decrease your overall portfolio volatility.